М. Б. Запорожченко

ORCID: 0000-0003-1450-9708 · 6 papers in corpus
article 2023
·doi:10.18370/2309-4117.2023.67.68-73

Objectives: development of an algorithm for managing women of reproductive age with adenomyosis of I–IV degrees of severity after COVID-19 by studying anamnestic, clinical, laboratory indicators, results of instrumental and hardware researc…

article 2023
·doi:10.35278/2664-0767.2(52).2023.298044

Purpose. To study the prevalence and forms of adenomyosis for women of reproductive age after COVID-19, to study pathomorphological changes in the uterine tissues of women of reproductive age with adenomyosis after COVID-19. Materials and …

article 2019
·doi:10.31393/reports-vnmedical-2019-23(1)-20

The combined pathology of the uterus, leiomyoma and adenomyosis, is one of the pressing problems of modern medicine, and is accompanied by a deficiency of vitamins, and the main macro-, trace elements. The purpose — to study the content of …

article 2019
·doi:10.18370/2309-4117.2019.50.51-55

Clinical assessment of the general status of patients with combined uterine pathology (leiomyoma (LM) and adenomyosis) has a practical importance for determining specific therapeutic tactics. The study of the general condition of reproducti…

article 2018
·doi:10.15574/hw.2019.137.114
article 2017
·doi:10.18370/2309-4117.2017.36.24-30

Endometriosis and leiomyoma commonly co-exist inside one uterus. Specialized surgical centers report detection frequency of comorbid endometriosis during surgery or laparoscopy that varies from 20 to 87% in patients with symptomatic fibroid…